Skip to content
by Legal Desire
10 February 2026

Latham Advises on Satellos’ US$50 Million Initial US Offering

Advising firms

Deal team

13 lawyers named
LawyerFirmSeniorityPracticeOffice
Nathan Ajiashvili Lead Latham & Watkins LLP Partner Capital Markets New York
Adam Gelardi Lead Latham & Watkins LLP Partner Capital Markets New York
KC Sands Latham & Watkins LLP Associate Capital Markets New York
Emma Gilmore Latham & Watkins LLP Associate Capital Markets New York
Molly Mitchell Latham & Watkins LLP Associate Capital Markets New York
Andrea Ramezan-Jackson Latham & Watkins LLP Partner tax Washington, D.C.
Tessa Young Latham & Watkins LLP Associate tax Washington, D.C.
Elizabeth Richards Latham & Watkins LLP Partner FDA regulatory Washington, D.C.
Evan Miller Latham & Watkins LLP Associate FDA regulatory Washington, D.C.
Betty Pang Latham & Watkins LLP Partner healthcare regulatory Bay Area
Eliot Choy Latham & Watkins LLP Counsel intellectual property New York
Arun Mohan Latham & Watkins LLP Associate intellectual property New York
Patrick Chew Latham & Watkins LLP Associate intellectual property New York

10 more lawyers on this deal. Register free to see the full deal team, with seniority, practice and office.

REGISTER FREE SIGN IN

Want co-counsel patterns, repeat clients and alerts when these firms land their next deal? Get Pro.

Stated terms

Stated value
USD 50m (US$50 Million)
What the figure measures
Issue size
Client
Latham & Watkins LLPUnderwriters
Counterparties
Satellos Bioscience Inc. (Issuer)